Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Net Income (Quarterly): -161.90M for Sept. 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -161.90M |
| June 30, 2023 | -176.91M |
| March 31, 2023 | -184.59M |
| December 31, 2022 | -202.48M |
| September 30, 2022 | -173.56M |
| June 30, 2022 | -176.44M |
| March 31, 2022 | -188.39M |
| December 31, 2021 | -199.62M |
| September 30, 2021 | -80.05M |
| June 30, 2021 | -166.28M |
| March 31, 2021 | -135.68M |
| December 31, 2020 | -101.66M |
| September 30, 2020 | -88.16M |
| June 30, 2020 | -81.28M |
| March 31, 2020 | -86.66M |
| December 31, 2019 | -72.38M |
| September 30, 2019 | -54.17M |
| June 30, 2019 | -45.54M |
| March 31, 2019 | -40.75M |
| December 31, 2018 | -28.24M |
| September 30, 2018 | -27.47M |
| June 30, 2018 | -27.72M |
| March 31, 2018 | -15.00M |
| December 31, 2017 | -17.95M |
| September 30, 2017 | -16.35M |
| Date | Value |
|---|---|
| June 30, 2017 | -18.44M |
| March 31, 2017 | -17.78M |
| December 31, 2016 | -19.77M |
| September 30, 2016 | -19.46M |
| June 30, 2016 | -22.03M |
| March 31, 2016 | -21.89M |
| December 31, 2015 | -18.38M |
| September 30, 2015 | -18.74M |
| June 30, 2015 | -15.46M |
| March 31, 2015 | -11.94M |
| December 31, 2014 | -10.40M |
| September 30, 2014 | -8.629M |
| June 30, 2014 | -11.01M |
| March 31, 2014 | -13.65M |
| December 31, 2013 | -11.25M |
| September 30, 2013 | -29.40M |
| June 30, 2013 | -8.012M |
| March 31, 2013 | -4.217M |
| December 31, 2012 | -6.307M |
| September 30, 2012 | -5.946M |
| June 30, 2012 | -4.677M |
| March 31, 2012 | -3.356M |
| December 31, 2011 | -3.627M |
| September 30, 2011 | -2.967M |
| June 30, 2011 | -1.520M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-202.48M
Minimum
Dec 2022
-72.38M
Maximum
Dec 2019
-142.25M
Average
-164.09M
Median
Net Income (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 1.211B |
| Karuna Therapeutics Inc (DELISTED) | -113.82M |
| Puma Biotechnology Inc | 20.32M |
| NovaBay Pharmaceuticals Inc | -1.212M |
| Palatin Technologies Inc | -8.250M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 16.40M |
| Total Expenses (Quarterly) | 188.45M |
| EPS Diluted (Quarterly) | -2.49 |
| Gross Profit Margin (Quarterly) | 89.71% |
| Profit Margin (Quarterly) | -987.2% |